Funding Details
- Awarder
- Inbox
- Date Award
- May 18, 2025
- Vertical
- Biotech
- Funding URL
- View Funding Page
Company Info
- Traction
- LimmaTech has initiated a Phase 1 clinical trial for LBT-SA7, with initial results expected in the second half of 2025.
- Company Description
- LimmaTech is a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, specifically targeting Staphylococcus aureus infections.
- Market
- Healthcare
- Location
-
Switzerland
Links